Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Crossref DOI link: https://doi.org/10.1007/s40263-015-0265-8
Published Online: 2015-08-07
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kumar, Gyanendra
Uhrig, Drew
Fowler, Susan
DeLaney, Matthew C.
Alexandrov, Andrei V.
Text and Data Mining valid from 2015-08-01